{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7191,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The slide features both the Aeglea and Spyre Therapeutics logos, indicating a transition or merger context.",
      "imagePath": "https://imgproxy.kitesheet.com/fP2olevAOiGWuUVMRCp3PoNbSJbJ1aD8XjWdfm_EIas/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZTZmNmZmYjFhN2VjYjI3ODI3NmRjYmQ2OGJkMWQ3Ny9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/1",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/HB4acLJv_1BiYcX91ggomBM30UwTP6A_iC2iW1GcPHs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZTZmNmZmYjFhN2VjYjI3ODI3NmRjYmQ2OGJkMWQ3Ny9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/71_PhsMWZPClbkArUuf2AjuMEdP5jJmQnoeL1FfcG6c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZTZmNmZmYjFhN2VjYjI3ODI3NmRjYmQ2OGJkMWQ3Ny9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/o-WpA0ta3n_vTu5N7a9ACi5GzpT_1_eFjW8r2iTBZS4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ZTZmNmZmYjFhN2VjYjI3ODI3NmRjYmQ2OGJkMWQ3Ny9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/2",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "other",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/3",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a footnote regarding a 1-for-25 reverse stock split.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/4",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a pipeline chart format to show the development status of seven different programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/5",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/6",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a donut chart to illustrate market growth from 2021 to 2028.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/7",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The chart uses a visual metaphor of an arrow pointing from current standard of care (SOC) to a higher efficacy/convenience target.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/8",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 8,
          "beatId": "7af050bc-2753-4f31-9805-17415e57f291",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the limitations of current biologics and the need for new approaches.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": "The slide uses a numbered list format to present strategic pillars.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/9",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a visual representation of an antibody molecule with callouts to specific engineering improvements, supported by a scatter plot showing clinical precedent for half-life extension.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/10",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-10",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "why_now",
      "function": "cite_precedent",
      "notes": "Uses a visual metaphor of antibody combination to explain the therapeutic strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/11",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-11",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        },
        {
          "to": 11,
          "from": 11,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "8e9697fd-79aa-4fe8-a218-0ec6e1bba9da",
          "evidence": "The document highlights the growing market and the need for improved solutions.",
          "position": 1,
          "objective": "Why now is the right time for Spyre's IBD treatment solutions?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "solution",
      "function": "cite_precedent",
      "notes": "The slide uses a Venn diagram to represent the intersection of genetic targets and a bar chart to demonstrate the efficacy of patient selection.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/12",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-12",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style pipeline visualization to show progress of seven distinct programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/13",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-13",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style layout to show progress across Discovery, IND-Enabling, and Clinical stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/14",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-14",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a KOL quote and two charts: a bar chart for global sales and a line chart for market share.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/15",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-15",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 8,
          "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The chart uses a vertical axis to imply a safety spectrum (Safest to Riskiest) and a horizontal axis for efficacy (clinical remission %).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/16",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-16",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a checkmark/arrow matrix to highlight competitive differentiation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/17",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-17",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a standard antibody diagram to annotate specific engineering improvements.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/18",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-18",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes structural visualization of the epitope and two dose-response curves.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/19",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-19",
      "loopMatches": [
        {
          "to": 19,
          "from": 10,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "81dafa0c-0003-4cb7-a116-4ee57350754d",
          "evidence": "The document presents SPY001 as a potentially best-in-class anti-α4β7 mAb.",
          "position": 0,
          "objective": "What if Spyre's mAbs could provide a best-in-class solution for IBD treatment?",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "The chart shows dose-response curves for three donors; the table summarizes the calculated EC50 values.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/20",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart uses a log-linear scale for concentration over time to demonstrate the beta-elimination phase.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/21",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart to compare pharmacokinetic properties between a proprietary drug candidate (SPY001) and a competitor (Entyvio).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/22",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Uses a visual timeline/comparison to contrast current standard of care with the proposed product.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/23",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart to show benchmark data alongside a specific exposure-response analysis for vedolizumab.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/24",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d059-759d-8e0a-99644712d3dd",
      "docSlug": "f911cd737b9fddb4d5979d6a089cb4fc",
      "documentTitle": "Yatsen | Results Presentation Deck | 17 slides",
      "authorId": "yatsen",
      "authorName": "Yatsen Holding Limited",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d059-759d-8e0a-99644712d3dd/12",
      "deckHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd",
      "deckAnchorHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 11,
          "beatId": "aa480793-8ee0-43e2-9340-77e91bbf94c9",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The presentation concludes with a financial review and a thank you note.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d059-759d-8e0a-99644712d3dd",
      "docSlug": "f911cd737b9fddb4d5979d6a089cb4fc",
      "documentTitle": "Yatsen | Results Presentation Deck | 17 slides",
      "authorId": "yatsen",
      "authorName": "Yatsen Holding Limited",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide explains the drivers behind the financial performance metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d059-759d-8e0a-99644712d3dd/13",
      "deckHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd",
      "deckAnchorHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 11,
          "beatId": "aa480793-8ee0-43e2-9340-77e91bbf94c9",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The presentation concludes with a financial review and a thank you note.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d059-759d-8e0a-99644712d3dd",
      "docSlug": "f911cd737b9fddb4d5979d6a089cb4fc",
      "documentTitle": "Yatsen | Results Presentation Deck | 17 slides",
      "authorId": "yatsen",
      "authorName": "Yatsen Holding Limited",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart shows a breakdown of R&D, G&A, S&M, and Fulfillment expenses.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d059-759d-8e0a-99644712d3dd/14",
      "deckHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd",
      "deckAnchorHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 11,
          "beatId": "aa480793-8ee0-43e2-9340-77e91bbf94c9",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The presentation concludes with a financial review and a thank you note.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d059-759d-8e0a-99644712d3dd",
      "docSlug": "f911cd737b9fddb4d5979d6a089cb4fc",
      "documentTitle": "Yatsen | Results Presentation Deck | 17 slides",
      "authorId": "yatsen",
      "authorName": "Yatsen Holding Limited",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide provides a detailed breakdown of adjustments made to GAAP net income to arrive at non-GAAP figures, including share-based compensation, amortization, and investment revaluations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d059-759d-8e0a-99644712d3dd/15",
      "deckHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd",
      "deckAnchorHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 11,
          "beatId": "aa480793-8ee0-43e2-9340-77e91bbf94c9",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The presentation concludes with a financial review and a thank you note.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d059-759d-8e0a-99644712d3dd",
      "docSlug": "f911cd737b9fddb4d5979d6a089cb4fc",
      "documentTitle": "Yatsen | Results Presentation Deck | 17 slides",
      "authorId": "yatsen",
      "authorName": "Yatsen Holding Limited",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart displays two distinct metrics: a running balance (top row) and quarterly cashflow (bars).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d059-759d-8e0a-99644712d3dd/16",
      "deckHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd",
      "deckAnchorHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 11,
          "beatId": "aa480793-8ee0-43e2-9340-77e91bbf94c9",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The presentation concludes with a financial review and a thank you note.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d059-759d-8e0a-99644712d3dd",
      "docSlug": "f911cd737b9fddb4d5979d6a089cb4fc",
      "documentTitle": "Yatsen | Results Presentation Deck | 17 slides",
      "authorId": "yatsen",
      "authorName": "Yatsen Holding Limited",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d059-759d-8e0a-99644712d3dd/17",
      "deckHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd",
      "deckAnchorHref": "/decks/019de075-d059-759d-8e0a-99644712d3dd#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 11,
          "beatId": "aa480793-8ee0-43e2-9340-77e91bbf94c9",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The presentation concludes with a financial review and a thank you note.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}